Abstract
A patient with eosinophilia-myalgia syndrome developed progressive central nervous system involvement that did not improve despite discontinuation of L- tryptophan therapy. Neurologic impairment was manifested initially by spastic monoparesis, which was improved by treatment with methylprednisolone and hydroxyurea. Recurrence of weakness was accompanied by gait ataxia, dysphagia, and complaints of a gradual decline in memory and concentration. Neuropsychological testing identified a broad pattern of cognitive deficits suggestive of a subcortical dementia, and magnetic resonance imaging demonstrated multiple high-signal lesions in the white matter. Cognitive deficits appear to be underrecognized in patients with the eosinophilia- myalgia syndrome. The response of our patient's initial symptoms to corticosteroid therapy suggests a possible role for autoimmune mechanisms in the pathogenesis of central nervous system involvement in the eosinophilia- myalgia syndrome. Neuropsychological evaluation should be performed in patients with cognitive complaints to delineate the full spectrum of central nervous system impairment associated with the eosinophilia-myalgia syndrome.
| Original language | English |
|---|---|
| Pages (from-to) | 1082-1085 |
| Number of pages | 4 |
| Journal | Archives of Neurology |
| Volume | 49 |
| Issue number | 10 |
| State | Published - Jan 1 1992 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Neuroscience(all)
Cite this
Central nervous system involvement in the eosinophilia-myalgia syndrome. / Lynn, J.; Rammohan, Kottil W; Bornstein, R. A.; Kissel, J. T.
In: Archives of Neurology, Vol. 49, No. 10, 01.01.1992, p. 1082-1085.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Central nervous system involvement in the eosinophilia-myalgia syndrome
AU - Lynn, J.
AU - Rammohan, Kottil W
AU - Bornstein, R. A.
AU - Kissel, J. T.
PY - 1992/1/1
Y1 - 1992/1/1
N2 - A patient with eosinophilia-myalgia syndrome developed progressive central nervous system involvement that did not improve despite discontinuation of L- tryptophan therapy. Neurologic impairment was manifested initially by spastic monoparesis, which was improved by treatment with methylprednisolone and hydroxyurea. Recurrence of weakness was accompanied by gait ataxia, dysphagia, and complaints of a gradual decline in memory and concentration. Neuropsychological testing identified a broad pattern of cognitive deficits suggestive of a subcortical dementia, and magnetic resonance imaging demonstrated multiple high-signal lesions in the white matter. Cognitive deficits appear to be underrecognized in patients with the eosinophilia- myalgia syndrome. The response of our patient's initial symptoms to corticosteroid therapy suggests a possible role for autoimmune mechanisms in the pathogenesis of central nervous system involvement in the eosinophilia- myalgia syndrome. Neuropsychological evaluation should be performed in patients with cognitive complaints to delineate the full spectrum of central nervous system impairment associated with the eosinophilia-myalgia syndrome.
AB - A patient with eosinophilia-myalgia syndrome developed progressive central nervous system involvement that did not improve despite discontinuation of L- tryptophan therapy. Neurologic impairment was manifested initially by spastic monoparesis, which was improved by treatment with methylprednisolone and hydroxyurea. Recurrence of weakness was accompanied by gait ataxia, dysphagia, and complaints of a gradual decline in memory and concentration. Neuropsychological testing identified a broad pattern of cognitive deficits suggestive of a subcortical dementia, and magnetic resonance imaging demonstrated multiple high-signal lesions in the white matter. Cognitive deficits appear to be underrecognized in patients with the eosinophilia- myalgia syndrome. The response of our patient's initial symptoms to corticosteroid therapy suggests a possible role for autoimmune mechanisms in the pathogenesis of central nervous system involvement in the eosinophilia- myalgia syndrome. Neuropsychological evaluation should be performed in patients with cognitive complaints to delineate the full spectrum of central nervous system impairment associated with the eosinophilia-myalgia syndrome.
UR - http://www.scopus.com/inward/record.url?scp=0026667406&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026667406&partnerID=8YFLogxK
M3 - Article
C2 - 1417516
AN - SCOPUS:0026667406
VL - 49
SP - 1082
EP - 1085
JO - Archives of Neurology
JF - Archives of Neurology
SN - 0003-9942
IS - 10
ER -